Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31true2023-11-28falseBusiness support services3true 15313188 2023-11-27 15313188 2023-11-28 2024-12-31 15313188 2023-01-01 2023-11-27 15313188 2024-12-31 15313188 c:Director1 2023-11-28 2024-12-31 15313188 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 15313188 d:ShareCapital 2024-12-31 15313188 d:RetainedEarningsAccumulatedLosses 2024-12-31 15313188 c:FRS102 2023-11-28 2024-12-31 15313188 c:Audited 2023-11-28 2024-12-31 15313188 c:AbridgedAccounts 2023-11-28 2024-12-31 15313188 c:PrivateLimitedCompanyLtd 2023-11-28 2024-12-31 15313188 c:SmallCompaniesRegimeForAccounts 2023-11-28 2024-12-31 15313188 2 2023-11-28 2024-12-31 15313188 e:PoundSterling 2023-11-28 2024-12-31 iso4217:GBP xbrli:pure
Registered number: 15313188













 
SSI DIAGNOSTICA (UK) LIMITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE PERIOD ENDED 31 DECEMBER 2024




































Page Kirk LLP
Chartered Accountants and Statutory Auditors
Sherwood House
7 Gregory Boulevard
Nottingham
NG7 6LB

 
SSI DIAGNOSTICA (UK) LIMITED
REGISTERED NUMBER:15313188

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2024
£
£

  

Current assets
  

Debtors
  
22,689

Cash at bank and in hand
  
1,619

  
24,308

Creditors: amounts falling due within one year
  
(18,822)

Net current assets
  
 
 
5,486

Total assets less current liabilities
  
5,486

  

Net assets
  
5,486


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
5,386

  
5,486


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.
All of the company's members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 April 2025.




Mrs C C Lindved
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
SSI DIAGNOSTICA (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

1.


General information

The company is a private company limited by share capital incorporated in England and Wales.
The address of its registered office is:
Sherwood House
7 Gregory Boulevard
Nottingham
England
NG7 6LB
These financial statements were authorised for issue by the Board on 10 April 2025.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

Page 2

 
SSI DIAGNOSTICA (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
SSI DIAGNOSTICA (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the period was 3.

Page 4

 
SSI DIAGNOSTICA (UK) LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

4.


Controlling party

SSI Diagnostica A/S is the parent company of a group of companies containing SSI Diagnostica (UK) Limited which prepares consolidated financial statements. SSI Diagnostica A/S registered office address is - SSI Diagnostica A/S, Herredsvejen 2, 3400 Hillerød, Denmark.


5.


Auditors' information

The auditors' report on the financial statements for the period ended 31 December 2024 was unqualified.

The audit report was signed on 10 April 2025 by John Wallis (Senior Statutory Auditor) on behalf of Page Kirk LLP.

 
Page 5